Information Library
Thought leadership - Phase I/IIa
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Drug Information Association (DIA) US 2010
June 13 - June 16, 2010
Exhibit Dates: June 13 - 16, 2010 Exhibitor Booth Number: 1035 Quintiles Speakers: TBD -
ASCO 2010 Annual Meeting
June 4 - June 8, 2010
Exhibit Dates: June 5 - 7, 2010 Exhibitor Booth Number: 2053 -
Changing the Face of Cancer Research
August 31, 2009
Christopher Ung, Vice President, Strategic Business & Operations, Oncology, at TMD, a Quintiles Central Laboratory, explains how advances in biomarker technology are ushering in a new era of cancer therapy development. -
Championing the Clinical Trial
March 31, 2009
Quintiles’ ethical standards and review procedures ensure patient safety remains the top priority for all clinical trials. The company is also leading the way for data transparency, so drug trial sponsors have instant access to information about the conduct and status of trials.
Page 1 of 1 (4 items)